Accelerate Protein Engineering with Artificial Intelligence and Machine Learning

AI Protein Design for Next-Generation Protein Engineering

Artificial intelligence is transforming protein engineering by enabling researchers to explore vast protein sequence spaces more efficiently than traditional trial-and-error approaches. Instead of experimentally testing thousands of variants, AI-guided protein design helps prioritize promising candidates before laboratory validation.

Neoncorte Bio combines artificial intelligence, machine learning, protein language models, and computational biology to support the design and optimization of enzymes, antibodies, therapeutic proteins, and other biologics.

Our AI-driven workflows complement laboratory experimentation and help accelerate Design-Build-Test-Learn (DBTL) cycles.

What Is AI Protein Design?

AI protein design applies machine learning algorithms and computational biology to predict how amino acid substitutions may influence protein function and developability.

Rather than relying solely on large-scale experimental screening, AI-assisted methods help researchers:
  • Prioritize beneficial mutations
  • Explore larger sequence spaces
  • Reduce unnecessary laboratory experiments
  • Optimize multiple protein properties simultaneously
  • Improve engineering efficiency
  • Support informed decision-making throughout R&D

AI Technologies Behind Our Platform

Neoncorte Bio integrates modern computational technologies, including:
  • Protein language models (PLMs)
  • Machine learning
  • Artificial intelligence
  • Structure-informed protein modeling
  • Computational mutagenesis
  • Virtual Deep Mutational Scanning (DMS)
  • Protein fitness landscape prediction
  • Epistasis prediction
  • Higher-order mutation prediction
  • Active learning
  • Bayesian optimization
  • Multi-objective optimization
These technologies help prioritize variants for experimental validation while supporting iterative optimization.

AI Protein Design Capabilities

Our computational workflows support:
  • AI Protein Design
    Rational Mutation Prioritization
    Predict amino acid substitutions likely to improve target protein properties.
  • AI Protein Design
    Computational Mutagenesis
    Evaluate the predicted impact of individual mutations and mutation combinations before laboratory experiments.
  • AI Protein Design
    Virtual Deep Mutational Scanning
    Analyze millions of potential sequence variants computationally.
  • AI Protein Design
    Protein Fitness Landscape Analysis
    Model sequence-function relationships to identify productive engineering trajectories.
  • AI Protein Design
    Smart Library Design
    Generate focused mutation libraries that reduce screening while maintaining sequence diversity.
  • AI Protein Design
    Multi-Parameter Optimization
    Optimize several protein properties simultaneously instead of improving one characteristic at a time.

Engineering Objectives

AI protein design can support optimization of:
  • Protein stability
  • Thermostability
  • Melting temperature (Tm)
  • Catalytic activity
  • Catalytic efficiency
  • Binding affinity
  • Protein developability
  • Manufacturability
  • Expression yield
  • Aggregation resistance
  • Protein solubility
  • pH stability
  • Solvent tolerance
  • Oxidative stability
  • Freeze-thaw stability
  • Cofactor specificity
  • Substrate specificity
  • Enantioselectivity
  • Antibody viscosity
  • Multi-parameter optimization
Optimization strategies are tailored to each protein and research objective.

Protein Types Supported

Our AI protein design platform can be applied to:

  • Industrial enzymes
  • Therapeutic proteins
  • Monoclonal antibodies
  • Antibody fragments
  • Cytokines
  • Growth factors
  • Diagnostic proteins
  • Biosensor proteins
  • Receptor proteins
  • Synthetic biology proteins
  • Novel protein scaffolds
  • Fusion proteins
  • Engineered enzymes

Industries We Support

AI Protein Design
  • Biopharmaceutical Development

    Design and optimize therapeutic proteins, biologics, and antibody candidates.
  • Industrial Biotechnology

    Engineer enzymes and proteins for sustainable manufacturing and biocatalysis.
  • Synthetic Biology

    Improve proteins used in engineered metabolic pathways and microbial production systems.
  • Diagnostics

    Optimize proteins for molecular diagnostics and biosensor applications.
  • Environmental Biotechnology

    Develop proteins for biodegradation, recycling, and environmental remediation.
AI Protein Design

Design-Build-Test-Learn (DBTL) Collaboration

Our AI protein design workflow supports every phase of iterative protein engineering.
Design
Analyze protein sequences, structures, and engineering goals.
Build
Prioritize mutations and focused variant libraries.
Test
Experimentally evaluate engineered proteins.
Learn
Use experimental data to continuously improve predictive models.

Each DBTL cycle refines computational predictions and accelerates future engineering campaigns.
ai protein design dbtl cycle

Why Choose Neoncorte Bio?

Neoncorte Bio combines expertise in:
  • Artificial intelligence
  • Machine learning
  • Computational protein engineering
  • Protein language models
  • Structural biology
  • Computational mutagenesis
  • Virtual Deep Mutational Scanning
  • Protein fitness landscape prediction
  • Epistasis prediction
  • Higher-order mutation prediction
  • Active learning
  • Bayesian optimization
  • Multi-objective optimization
  • Design-Build-Test-Learn (DBTL)
Our AI-guided workflows help research teams make more informed engineering decisions while complementing laboratory experimentation.

Who Uses AI Protein Design?

Our platform supports:
  • Biotechnology companies
  • Pharmaceutical companies
  • Industrial enzyme manufacturers
  • Antibody developers
  • Synthetic biology startups
  • Diagnostic companies
  • CROs and CDMOs
  • Academic research laboratories
Frequently Asked Questions (FAQs)
Neoncorte Bio
Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering
Proud Member of Leading Global AI Programs
Neoncorte Bio is part of the NVIDIA Inception and Nebius for Startups programs — two of the world’s leading ecosystems for high-performance AI innovation. These partnerships strengthen our ability to deliver next-generation AI-driven protein, enzyme, and aptamer engineering.
  • NVIDIA Inception Neoncorte Bio AI life sciences company
    As a member of NVIDIA Inception, Neoncorte Bio gains access to cutting-edge GPU technologies, expert guidance, and a global AI ecosystem that supports companies from prototype to production. The program empowers us to explore new AI opportunities and build high-performance biological design pipelines powered by NVIDIA’s world-class platform.
  • Nebius AI life sciences Neoncorte Bio
    Through Nebius for Startups, we gain access to high-performance compute infrastructure optimized for large-scale AI workloads, along with hands-on technical guidance and a strong community of innovative AI companies. Nebius enables us to train and deploy complex biological models more efficiently — accelerating enzyme, protein, and aptamer design while supporting rapid scaling of our R&D pipelines.
Publications
Scientific Publication of Neoncorte Bio Team
  • Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
  • The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
  • List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio

Our Expertise in Action
With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
  • Automated NGS Data Analysis:
    Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
  • Single-Cell Data Integration:
    Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
  • Metagenomic Classification Algorithms:
    Developed advanced methods for classifying sequencing reads in metagenomics research.
  • High-Throughput Image Processing Pipelines:
    Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
  • Cell Counting via AI:
    Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com